Skip to content
LicenseRef-EPAD-VIMI-Terms ยท custom agreement

EPAD Terms and Conditions for accessing the V.IMI Dataset

One-page terms accepted when requesting EPAD LCS data or images through the AD Data Initiative. The data serve Alzheimer's disease research, analyses should follow the research question submitted with the request and be published, data must not be passed to third parties, and publications must carry set acknowledgement elements.

Original license text Edit Purpose: Approved project only Version read: Document version 2.0, 1 June 2021 Checked 2026-10-08
GA4GH DUO: PS

Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer

In your favor With conditions Restricts you Not stated in the text

What you can do

  • Not stated
  • Train ML models Not stated
  • Create derived data Not stated
  • Yes

What you can share

  • No
  • Not stated
  • Share trained models Not stated

What you must do

  • Yes
  • Share alike No
  • Yes
  • Ethics approval No
  • Not stated
  • Release code No
  • Return results No
  • Delete after use No

Limits

  • No
  • No

Datasets under this license

  • EPAD LCS

    European multi-site cohort of 2,096 adults aged 50 or over without dementia, many amyloid positive, with longitudinal 3D T1w, FLAIR, T2w and T2*w MRI, SWI, fMRI, diffusion and ASL at a subset of sites, CSF biomarkers and cognitive data. Access by request through the AD Data Initiative.